Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology.
$0.69+11.03%
报价 2026-11-06
市值
$87.7M
EV
$85.4M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -62.2%
$0.62$1.82
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| TLSATiziana Life Sciences Ltd | $87.7M | +11.0% | – | 0% | – | – | – | |
| SEERSeer, Inc. | $90.3M | -4.1% | -4.1% | 47% | – | – | – | |
| CBUSCibus, Inc. | $90.2M | +3.5% | +90.0% | 72.1% | – | – | – | |
| ICCCImmuCell Corporation | $89M | -1.5% | 0.0% | 40.3% | 127.5x | 28.6x | 23.2x | |
| GNLXGenelux Corporation | $88.7M | +7.7% | +32019.5% | -3,537.5% | – | – | – | |
| RLYBRallybio Corporation | $84.8M | +0.4% | -85.7% | 99.7% | – | – | – | |
| INOInovio Pharmaceuticals, Inc. | $83.9M | -16.2% | +10800.0% | 0% | – | – | – | |
| VTVTvTv Therapeutics Inc. | $83.2M | -3.3% | +1230.0% | 50% | – | – | – | |
| TNYATenaya Therapeutics, Inc. | $82.1M | +14.0% | +304.8% | 116.1% | – | – | – | |
| 同行中位数 | – | – | +197.4% | 48.5% | 127.5x | 28.6x | 23.2x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。